2-Furfurylthio-3-methylpyrazine | CAS:65530-53-2

We serve 2-Furfurylthio-3-methylpyrazine CAS:65530-53-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Furfurylthio-3-methylpyrazine

Chemical Name:2-Furfurylthio-3-methylpyrazine
CAS.NO:65530-53-2
Synonyms:2-Methyl-3,5-furfurylthiopyrazine
2-Methyl-3,6-furfurylthiopyrazine
2-Furfurylthio-3-methylpyrazine
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 314.7±42.0 °C at 760 mmHg
Molecular Formula C10H10N2OS
Molecular Weight 206.264
Flash Point 144.1±27.9 °C
 
Specification:
Appearance:Colorless liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate



Contact us for information like 2-Methyl-3,5-furfurylthiopyrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Furfurylthio-3-methylpyrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Furfurylthio-3-methylpyrazine Use and application,2-Furfurylthio-3-methylpyrazine technical grade,usp/ep/jp grade.


Related News: A system that allows Chinese citizens to enter South Korea’s Jeju Island without a visa is to be temporarily suspended.4-Chlorobenzenesulfonyl chloride manufacturer A system that allows Chinese citizens to enter South Korea’s Jeju Island without a visa is to be temporarily suspended.methyl (2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoate,hydrochloride supplier China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.(Z)-2-Methoxyimino-2-(Fur-2-yl)-Aceticacid Ammonium Salt vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases.Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.